User profiles for M. Theobald

Michael Theobald

- Verified email at deshawresearch.com - Cited by 3998

Mark Richard Theobald

- Verified email at ciemat.es - Cited by 2913

Maryanne Theobald

- Verified email at qut.edu.au - Cited by 1415

Challenges in quantifying biosphere–atmosphere exchange of nitrogen species

…, JE Olesen, U Dragosits, MR Theobald… - Environmental …, 2007 - Elsevier
Recent research in nitrogen exchange with the atmosphere has separated research communities
according to N form. The integrated perspective needed to quantify the net effect of N …

Ecological impacts of atmospheric pollution and interactions with climate change in terrestrial ecosystems of the Mediterranean Basin: Current research and future …

…, A Santos, P Sicard, CJ Stevens, MR Theobald - Environmental …, 2017 - Elsevier
Mediterranean Basin ecosystems, their unique biodiversity, and the key services they provide
are currently at risk due to air pollution and climate change, yet only a limited number of …

Child participation in the early years: Challenges for education

M Theobald, S Danby… - Australasian Journal of …, 2011 - journals.sagepub.com
THE VIEW THAT CHILDREN should have a say in and participate in the decision making of
matters that affect them is now an accepted position when considering research and policy …

[PDF][PDF] Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse

…, H Dombret, C Karanes, M Theobald… - Journal of Clinical …, 2001 - Citeseer
Purpose: Three open-label, multicenter trials were conducted to evaluate the efficacy and
safety of singleagent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Laboratories, …

Anton, a special-purpose machine for molecular dynamics simulation

…, EC Priest, Y Shan, J Spengler, M Theobald… - Communications of the …, 2008 - dl.acm.org
The ability to perform long, accurate molecular dynamics (MD) simulations involving proteins
and other biological macro-molecules could in principle provide answers to some of the …

Anton 2: raising the bar for performance and programmability in a special-purpose molecular dynamics supercomputer

…, J Spengler, PTP Tang, M Theobald… - SC'14: Proceedings …, 2014 - ieeexplore.ieee.org
Anton 2 is a second-generation special-purpose supercomputer for molecular dynamics
simulations that achieves significant gains in performance, programmability, and capacity …

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in …

…, WLJ Van Putten, LF Verdonck, M Theobald… - Blood, 2007 - ashpublications.org
… 2 for 7 days) and a second cycle of amsacrine with intermediate-dose cytarabine (1000
mg/m 2 every 12 hours for 6 days). If CR occurred, patients in the AML4/4A protocol were …

Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence

…, M Theobald, D Voliotis, JM Bennett, M Richie… - Cancer, 2005 - Wiley Online Library
BACKGROUND In this study, the authors analyzed the efficacy and safety of gemtuzumab
ozogamicin (GO) (Mylotarg®), an antibody‐targeted chemotherapy for CD33‐positive acute …

Cerebral MR venography: normal anatomy and potential diagnostic pitfalls

…, PJ Keller, FJ McCully, MR Theobald… - American Journal …, 2000 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: MR venography is often used to examine the intracranial
venous system, particularly in the evaluation of dural sinus thrombosis. The purpose of this …

[HTML][HTML] Cytarabine dose for acute myeloid leukemia

…, MR Schaafsma, M Gregor, M Theobald… - … England Journal of …, 2011 - Mass Medical Soc
Background Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia
(AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) …